BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30339741)

  • 1. Thymic localization of erythrodermic cutaneous T-cell lymphoma.
    Bonnet P; Battistella M; Bouaziz JD; Ram-Wolff C; Frumholtz L; Herms F; Clerc G; Bonhomme A; Brice P; Bagot M; de Masson A
    Br J Dermatol; 2019 Feb; 180(2):427-428. PubMed ID: 30339741
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycosis fungoides and Sézary syndrome: Australian clinical practice statement.
    Bhabha FK; McCormack C; Wells J; Campbell BA; Newland K; Lade S; Buelens O; Joske D; Shortt J; Mapp S; Radeski D; Hertzberg M; Khot A; Van Der Weyden C; Khoo C; Hawkes E; Prince HM
    Australas J Dermatol; 2021 Feb; 62(1):e8-e18. PubMed ID: 33368169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Item no 164: malignant lymphoma: cutaneous lymphoma].
    CEDEF
    Ann Dermatol Venereol; 2008 Nov; 135(11 Suppl):F160-2. PubMed ID: 18984207
    [No Abstract]   [Full Text] [Related]  

  • 4. New options in diagnosis and management of mycosis fungoides and Sézary syndrome.
    Enke CA
    Oncology (Williston Park); 2010 May; 24(6):507-8. PubMed ID: 20568591
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous T-cell lymphoma-Focus on some problems, and some solutions.
    Beltraminelli H
    Hematol Oncol; 2023 Jun; 41 Suppl 1():20-24. PubMed ID: 37294972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical characteristics of mycosis fungoides and Sézary syndrome].
    Krc L; Dobesová J; Bucek M; Dusek J; Macák J; Galuszková D; Jurysek O
    Vnitr Lek; 1997 May; 43(5):285-9. PubMed ID: 9601850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating CD4+CD7- lymphocyte burden and rapidity of response: predictors of outcome in the treatment of Sézary syndrome and erythrodermic mycosis fungoides with extracorporeal photopheresis.
    Stevens SR; Baron ED; Masten S; Cooper KD
    Arch Dermatol; 2002 Oct; 138(10):1347-50. PubMed ID: 12374541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cutaneous T-cell lymphoma].
    Dippel E; Gellrich S; Klemke CD; Goerdt S; Sterry W
    J Dtsch Dermatol Ges; 2003 Dec; 1(12):965-80; quiz 981-2. PubMed ID: 16285650
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous T-cell lymphoma.
    Lansigan F; Choi J; Foss FM
    Hematol Oncol Clin North Am; 2008 Oct; 22(5):979-96, x. PubMed ID: 18954747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycosis Fungoides and Sézary Syndrome: An Update.
    Larocca C; Kupper T
    Hematol Oncol Clin North Am; 2019 Feb; 33(1):103-120. PubMed ID: 30497668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
    Edelson RL
    J Am Acad Dermatol; 1980 Feb; 2(2):89-106. PubMed ID: 6988470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous T-cell lymphoma (mycosis fungoides).
    Lorincz AL
    Lancet; 1996 Mar; 347(9005):871-6. PubMed ID: 8622396
    [No Abstract]   [Full Text] [Related]  

  • 13. How we treat mycosis fungoides and Sézary syndrome.
    Khan N; Noor SJ; Horwitz S
    Clin Adv Hematol Oncol; 2021 Sep; 19(9):573-581. PubMed ID: 34495021
    [No Abstract]   [Full Text] [Related]  

  • 14. A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome.
    Benton EC; Crichton S; Talpur R; Agar NS; Fields PA; Wedgeworth E; Mitchell TJ; Cox M; Ferreira S; Liu P; Robson A; Calonje E; Stefanato CM; Wilkins B; Scarisbrick J; Wain EM; Child F; Morris S; Duvic M; Whittaker SJ
    Eur J Cancer; 2013 Sep; 49(13):2859-68. PubMed ID: 23735705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.
    Whittaker SJ; Marsden JR; Spittle M; Russell Jones R; ;
    Br J Dermatol; 2003 Dec; 149(6):1095-1107. PubMed ID: 14696593
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cutaneous lymphomas : Clinical presentation - diagnosis - treatment].
    Wobser M; Goebeler M
    Hautarzt; 2019 Oct; 70(10):815-830. PubMed ID: 31511903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycosis fungoides.
    Gaeke ME; Variakojis D; Sweet DL
    Curr Probl Cancer; 1981 Sep; 6(3):1-39. PubMed ID: 7285618
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycosis fungoides and sezary syndrome: an update.
    Kim EJ; Lin J; Junkins-Hopkins JM; Vittorio CC; Rook AH
    Curr Oncol Rep; 2006 Sep; 8(5):376-86. PubMed ID: 16901399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous T cell lymphomas: mycosis fungoides, Sézary syndrome and lymphomatoid papulosis--Part I.
    Safai B
    Clin Bull; 1977; 7(3):91-7. PubMed ID: 308870
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.